Exenatide and Dapagliflozin Combination Enhances Sertoli Cell Secretion of Key Metabolites for Spermatogenesis

The incidence of metabolic diseases such as type 2 diabetes mellitus (DM) and obesity has been increasing dramatically. Both diseases are closely linked and new approaches for type 2 DM treatment aim to enable weight loss. A combined therapy of dapagliflozin and exenatide has been used against type...

Descripción completa

Detalles Bibliográficos
Autores principales: Ribeiro, João C., Martins, Ana D., Jarak, Ivana, Carvalho, Rui A., Alves, Marco G., Oliveira, Pedro F.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9139030/
https://www.ncbi.nlm.nih.gov/pubmed/35625851
http://dx.doi.org/10.3390/biomedicines10051115

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9139030/
https://www.ncbi.nlm.nih.gov/pubmed/35625851
http://dx.doi.org/10.3390/biomedicines10051115

Ejemplares similares